Drug Eluting Stents Market, by Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, and Others), by Coating Type (Polymer-based Coatings and Polymer-free Coatings), by Application (Coronary Artery Disease and Peripheral Artery Disease), by End

Drug Eluting Stents Market, by Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, and Others), by Coating Type (Polymer-based Coatings and Polymer-free Coatings), by Application (Coronary Artery Disease and Peripheral Artery Disease), by End User (Cardiology Centers, Ambulatory Surgery Centers (ASCs), and Hospitals), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Stents are usually used in the treatment of coronary angioplasty or percutaneous coronary intervention producers. The types of drug eluting stents include bare metal coronary artery stents, coronary artery restenosis, coronary artery stents, coronary revascularization, and others. Coronary artery stents are small cylindrical device that helps in improving blood flow through arteries to the heart by reducing blockages in the artery. Coronary artery stents are more beneficial for patients suffering from coronary artery diseases such as myocardial infarction.

Market Dynamics

Different Manufacturers like Boston Scientific., Medtronic, and others are focused on developing and launching new products and receiving product approvals from the United States Food and Drug Administration (U.S.FDA). For instance, in April 2019, Shanghai-based medical company MicroPort Medical (Group) Co., Ltd. received the U.S.FDA approval and CE (Conformité Européenne) Mark for ‘Firehawk Liberty’, a new generation rapamycin target eluting coronary stent system.

Furthermore, in May 2022, key players such as Medtronic, a global medical technology company, obtained the U.S. Food and Drug Administration (FDA) approval for Onyx Frontier drug-elution stent (DES), used to treat blockage of the heart arteries. It has enhanced delivering system and increased acute performance which is used to treat patients suffering from coronary artery disease. Onyx Frontier provides 4.50-5.00 mm sizes that can be expanded to 6.00 mm. It is specifically, designed to support extra-large vessels, while it shares the clinical indications as Resolute Onyx, including the most recent approval for patients that are at high risk of bleeding and may benefit from a dual anti-platelet therapy (DAPT) duration.

Moreover, an increase in the awareness of cardiovascular diseases such as heart failure and coronary heart disease cases globally is expected to fuel the global drug eluting stents market growth over the forecast period. For instance, in January 2020, according to the data published by the American Heart Association (AHA), the awareness of coronary artery disease is higher in females (54.4%) than males (45.6%). The mortality rate is also higher in females than in males with myocardial infarction (a dangerous condition caused by a lack of blood flow to the heart muscle).

Key features of the study:

  • This report provides an in-depth analysis of the global drug eluting stents market, market size (US$ Mn), and the compound annual growth rate (CAGR) (%) for the forecast period (2022-2030), considering 2021 as a base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global drug eluting stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launches, market expansion, and marketing tactics
  • Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic, Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys, AlviMedica Medical Technologies Inc., Amaranth Medical, Inc., HangZhou HuaAn Biotechnology Co., Ltd, XTENT, Inc., Cardionovum GmbH, Cordis Corporation, and Kyoto Medical Planning Co., Ltd.
  • The global drug eluting stents market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical device companies, new entrants, and financial analysts
  • The global drug eluting stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision-making through the various strategy matrices used in analyzing the global drug eluting stents market
Detailed Segmentation:
  • Global Drug Eluting Stents Market, By Drug
  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Others
  • Global Drug Eluting Stents Market, By Coating Type
  • Polymer-based Coatings
  • Polymer-free Coatings
  • Global Drug Eluting Stents Market, By Application:
  • Coronary Artery Diseases
  • Peripheral Artery Diseases
  • Global Drug Eluting Stents Market, By End User:
  • Cardiology Centers
  • Ambulatory Surgery Centers (ASCs)
  • Hospitals
  • Global Drug Eluting Stents Market, By Region
  • North America
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Boston Scientific Corporation
  • Company Overview
  • Product Portfolio
  • Market Presence
  • Financial Overview
  • Key Developments
  • Strategies
  • Medtronic, Plc.
  • Abbott Laboratories
  • Biosensors International Group
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical Corporation
  • Cook Medical
  • Shandong JW Medical Systems
  • Stentys
  • AlviMedica Medical Technologies Inc.
  • Amaranth Medical, Inc.
  • HangZhou HuaAn Biotechnology Co.,Ltd
  • XTENT, Inc.
  • Cardionovum GmbH
  • Cordis Corporation
  • Kyoto Medical Planning Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug
Market Snapshot, By Coating Type
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Product Approval and Launches
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory landscape
4. Global Drug Eluting Stents Market- Impact of Coronavirus (Covid-19) Pandemic
Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market
5. Global Drug Eluting Stents Market, By Drug, 2017–2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Sirolimus
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Paclitaxel
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Zotarolimus
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Ecerolimus
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Biolimus
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
6. Global Drug Eluting Stents Market, By Coating Type, 2017–2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Polymer-based Coatings
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Polymer-free Coatings
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
7. Global Drug Eluting Stents Market, By Application, 2017-2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Coronary Artery Disease
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Peripheral Artery Diseases
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
8. Global Drug Eluting Stents Market, By End User, 2017–2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Cardiology Centers
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Ambulatory Surgery Centers (ASCs)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Hospitals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
9. Global Drug Eluting Stents Market, By Region, 2017–2030, (US$ Million)
Introduction
Market Share Analysis, By Region, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Coating Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Coating Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Coating Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Coating Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Coating Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Coating Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Boston Scientific Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Medtronic
Abbott Laboratories
Biosensors International Group
Biotronik
Terumo Medical Corporation
Cook Medical
Stentys
Abbott Vascular Inc.
AlviMedica Medical Technologies Inc.
Amaranth Medical, Inc.
HangZhou HuaAn Biotechnology Co., Ltd
XTENT, Inc.
Cardionovum GmbH
Cordis Corporation
Kyoto Medical Planning Co., Ltd.
Shandong JW Medical Systems
11. Section
Research Methodology
About Us
*Browse 44 market data tables and 37 figures on "Global Drug Eluting Stents Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings